These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
951 related items for PubMed ID: 29777439
1. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Maharshak N, Ringel Y, Katibian D, Lundqvist A, Sartor RB, Carroll IM, Ringel-Kulka T. Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439 [Abstract] [Full Text] [Related]
2. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome. Li Y, Hong G, Yang M, Li G, Jin Y, Xiong H, Qian W, Hou X. Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562 [Abstract] [Full Text] [Related]
3. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome. Li G, Yang M, Jin Y, Li Y, Qian W, Xiong H, Song J, Hou X. J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775 [Abstract] [Full Text] [Related]
4. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Neurogastroenterol Motil; 2012 Jun; 24(6):521-30, e248. PubMed ID: 22339879 [Abstract] [Full Text] [Related]
5. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M. Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146 [Abstract] [Full Text] [Related]
6. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y. Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G799-807. PubMed ID: 21737778 [Abstract] [Full Text] [Related]
7. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives. Chen J, Lan H, Li C, Xie Y, Cheng X, Xia R, Ke C, Liang X. J Appl Microbiol; 2024 Jun 03; 135(6):. PubMed ID: 38849305 [Abstract] [Full Text] [Related]
8. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study. Hong G, Li Y, Yang M, Li G, Qian W, Xiong H, Bai T, Song J, Zhang L, Hou X. Neurogastroenterol Motil; 2020 Nov 03; 32(11):e13891. PubMed ID: 32449259 [Abstract] [Full Text] [Related]
9. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Shukla R, Ghoshal U, Dhole TN, Ghoshal UC. Dig Dis Sci; 2015 Oct 03; 60(10):2953-62. PubMed ID: 25784074 [Abstract] [Full Text] [Related]
10. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome. Yang J, Wang P, Liu T, Lin L, Li L, Kou G, Zhou R, Li P, Li Y. BMC Microbiol; 2021 Nov 13; 21(1):316. PubMed ID: 34773967 [Abstract] [Full Text] [Related]
12. Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression. Liu Y, Zhang L, Wang X, Wang Z, Zhang J, Jiang R, Wang X, Wang K, Liu Z, Xia Z, Xu Z, Nie Y, Lv X, Wu X, Zhu H, Duan L. Clin Gastroenterol Hepatol; 2016 Nov 13; 14(11):1602-1611.e5. PubMed ID: 27266978 [Abstract] [Full Text] [Related]
13. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J. Gut Microbes; 2016 Sep 02; 7(5):397-413. PubMed ID: 27662586 [Abstract] [Full Text] [Related]
15. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome. Wang Z, Xu CM, Liu YX, Wang XQ, Zhang L, Li M, Zhu SW, Xie ZJ, Wang PH, Duan LP, Zhu HQ. Chin Med J (Engl); 2019 Apr 20; 132(8):889-904. PubMed ID: 30958430 [Abstract] [Full Text] [Related]
16. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT. Dig Liver Dis; 2017 Apr 20; 49(4):331-337. PubMed ID: 28179092 [Abstract] [Full Text] [Related]
18. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Rangel I, Sundin J, Fuentes S, Repsilber D, de Vos WM, Brummer RJ. Aliment Pharmacol Ther; 2015 Nov 20; 42(10):1211-21. PubMed ID: 26376728 [Abstract] [Full Text] [Related]
19. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome. Hou Y, Dong L, Lu X, Shi H, Xu B, Zhong W, Ma L, Wang S, Yang C, He X, Zhao Y, Wang S. Dig Dis Sci; 2022 Dec 20; 67(12):5580-5592. PubMed ID: 35879512 [Abstract] [Full Text] [Related]
20. The microbiome of the oral mucosa in irritable bowel syndrome. Fourie NH, Wang D, Abey SK, Sherwin LB, Joseph PV, Rahim-Williams B, Ferguson EG, Henderson WA. Gut Microbes; 2016 Jul 03; 7(4):286-301. PubMed ID: 26963804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]